FBTAX
Fidelity Advisor Biotechnology Fund Class A
1W: -1.9%
1M: -8.1%
3M: +0.1%
YTD: +23.5%
1Y: +36.6%
3Y: +107.2%
5Y: +74.1%
$45.89
-0.01 (-0.02%)
Weekly Expected Move ±2.6%
$43
$45
$46
$47
$48
ETF-Level Metrics
AUM$2.2B
Holdings70
Top 10 Wt48.8%
Beta0.62
% Profitable7%
Coverage94%
Portfolio Valuation
P/E61.0
P/B29.7
P/S6.2
EV/EBITDA21.9
P/FCF20.9
PEG-4.88
Profitability & Returns
Gross Margin83.9%
Net Margin3.7%
ROE19.7%
ROA1.7%
ROIC21.8%
Div Yield0.55%
Leverage & Liquidity
Debt/Equity5.29
Debt/Assets0.49
Net Debt/EBITDA2.2x
Interest Cov6.0x
Current Ratio1.00
Quick Ratio0.85
Growth (YoY)
Revenue+47.6%
Net Income+21.7%
EPS+34.0%
FCF+16.0%
EBITDA+28.6%
Rev CAGR 3Y+46.6%
Quality Scores
Piotroski F4.3
Altman Z30.31
IS Quality57.1
IS Overall49.3
IS Value35.3
Median P/E-7.7
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 70 | 96.2% | -23.6 |
| Other | 28 | 6.3% | — |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | 2.05% | 3 | Bullish | 1 | 0 | +99.5% |
Showing 50 of 98 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | ABBVIE INC | 4AB.DE | 14.83% | $282.2M | 1,335,480 | 74.0 | $408.1B | Healthcare |
| 2 | ALNYLAM PHARMACEUTICALS INC | 0HD2.L | 5.52% | $105.1M | 339,486 | 36.0 | $29.7B | Healthcare |
| 3 | GILEAD SCIENCES INC | GILD.SW | 5.42% | $103.2M | 788,900 | -55.7 | $143.2B | Healthcare |
| 4 | INSMED INC | 0JAV.L | 3.51% | $66.7M | 489,600 | -27.0 | $23.7B | Healthcare |
| 5 | COGENT BIOSCIENCES INC | COGT | 3.45% | $65.7M | 1,834,818 | -13.4 | $5.3B | Healthcare |
| 6 | DIANTHUS THERAPEUTICS INC | DNTH | 3.37% | $64.1M | 730,062 | -678.5 | $4.9B | Healthcare |
| 7 | SPYRE THERAPEUTICS INC | AGLE | 3.33% | $63.4M | 851,772 | -6.0 | $49M | Healthcare |
| 8 | ASCENDIS PHARMA A/S | ASND | 3.24% | $61.8M | 269,225 | 16.7 | $14.2B | Healthcare |
| 9 | ARGENX SE | ARGNF | 3.17% | $60.3M | 77,200 | 33.3 | $58.2B | Healthcare |
| 10 | BIOGEN INC | BIIB.SW | 2.92% | $55.7M | 294,100 | 30.0 | $20.8B | Healthcare |
| 11 | ORUKA THERAPEUTICS INC | ORKA | 2.65% | $50.4M | 737,386 | -34.2 | $5.1B | Healthcare |
| 12 | Fidelity Revere Street Trust Private | — | 2.51% | $47.8M | 47,773,970 | — | — | — |
| 13 | AMGEN INC | 4332.HK | 2.46% | $46.8M | 135,103 | — | $998.5B | Healthcare |
| 14 | VAXCYTE INC | PCVX | 2.30% | $43.7M | 763,629 | -7.4 | $8.2B | Healthcare |
| 15 | REVOLUTION MEDICINES INC | RVMD | 2.27% | $43.2M | 299,500 | -23.3 | $43.9B | Healthcare |
| 16 | NUVALENT INC | NUVL | 2.17% | $41.3M | 412,264 | -20.5 | $9.1B | Healthcare |
| 17 | AMYLYX PHARMACEUTICALS INC | AMLX | 2.05% | $38.9M | 2,433,200 | -19.7 | $3.1B | Healthcare |
| 18 | APOGEE THERAPEUTICS INC | APGE | 1.97% | $37.5M | 452,639 | -31.1 | $8.4B | Healthcare |
| 19 | MODERNA INC | 0QF.F | 1.55% | $29.4M | 640,800 | -23.8 | $66.4B | Healthcare |
| 20 | XENON PHARMACEUTICALS INC | XENE | 1.34% | $25.6M | 456,458 | -8.0 | $3.7B | Healthcare |
| 21 | VIRIDIAN THERAPEUTICS INC | 0K1R.L | 1.26% | $24.0M | 1,782,464 | -5.5 | $1.7B | Healthcare |
| 22 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | KNSA | 1.18% | $22.5M | 417,600 | 70.8 | $5.8B | Healthcare |
| 23 | ROIVANT SCIENCES LTD | ROIVW | 1.16% | $22.2M | 776,700 | -4.3 | $2.0B | Healthcare |
| 24 | JADE BIOSCIENCES INC | JBIO | 1.15% | $21.8M | 894,343 | -5.1 | $859M | Healthcare |
| 25 | PRAXIS PRECISION MEDICINES INC. | PRAX | 1.14% | $21.6M | 67,900 | -22.8 | $8.2B | Healthcare |
| 26 | CRINETICS PHARMACEUTICALS INC | CRNX | 1.11% | $21.1M | 544,470 | -16.8 | $9.0B | Healthcare |
| 27 | CYTOKINETICS INC | CYTK | 1.05% | $20.0M | 312,871 | -9.1 | $8.2B | Healthcare |
| 28 | STRUCTURE THERAPEUTICS INC | GPCR | 1.05% | $19.9M | 481,200 | -9.1 | $1.6B | Healthcare |
| 29 | KYMERA THERAPEUTICS INC | KYMR | 0.99% | $18.8M | 231,700 | -33.0 | $8.8B | Healthcare |
| 30 | NATERA INC | NTRA | 0.97% | $18.4M | 89,400 | -301.7 | $58.8B | Healthcare |
| 31 | UCB SA | UCB.BR | 0.93% | $15.1M | 65,200 | 17.7 | $38.9B | Healthcare |
| 32 | NEWAMSTERDAM PHARMA COMPANY NV | NAMS | 0.88% | $16.7M | 586,400 | -10.6 | $2.7B | Healthcare |
| 33 | Fidelity Revere Street Trust Private | — | 0.77% | $14.7M | 14,682,049 | — | — | — |
| 34 | VIKING THERAPEUTICS INC | 0VQA.L | 0.74% | $14.0M | 450,187 | -6.4 | $3.5B | Healthcare |
| 35 | ENLIVEN THERAPEUTICS INC | ELVN | 0.71% | $13.6M | 328,862 | -28.6 | $3.4B | Healthcare |
| 36 | RELAY THERAPEUTICS INC | RLAY | 0.70% | $13.3M | 1,028,900 | -12.1 | $4.2B | Healthcare |
| 37 | FABIO TUB HOLDINGS LLC Private | — | 0.67% | $10.9M | 6,300 | — | — | — |
| 38 | TYRA BIOSCIENCES INC | TYRA | 0.65% | $12.3M | 354,200 | -8.5 | $1.2B | Healthcare |
| 39 | ZENAS BIOPHARMA INC | ZBIO | 0.62% | $11.8M | 610,924 | -2.9 | $1.8B | Healthcare |
| 40 | OLEMA PHARMACEUTICALS INC | OLMA | 0.59% | $11.2M | 777,200 | -3.9 | $718M | Healthcare |
| 41 | CELLDEX THERAPEUTICS INC | CLDX | 0.59% | $11.2M | 340,152 | -7.3 | $2.1B | Healthcare |
| 42 | TRAVERE THERAPEUTICS INC | TVTX | 0.56% | $10.7M | 253,600 | -126.5 | $5.3B | Healthcare |
| 43 | CG ONCOLOGY INC | CGON | 0.55% | $10.5M | 157,700 | -25.0 | $5.9B | Healthcare |
| 44 | STOKE THERAPEUTICS INC | STOK | 0.55% | $10.4M | 317,700 | -7.6 | $1.7B | Healthcare |
| 45 | ANNEXON INC | ANNX | 0.51% | $9.8M | 1,661,500 | -3.6 | $687M | Healthcare |
| 46 | RHYTHM PHARMACEUTICALS INC | RYTM | 0.50% | $9.6M | 117,433 | -29.8 | $6.4B | Healthcare |
| 47 | CYTOMX THERAPEUTICS INC | CTMX | 0.49% | $9.4M | 2,229,051 | -5.7 | $557M | Healthcare |
| 48 | DISC MEDICINE INC | IRON | 0.49% | $9.4M | 142,322 | -9.8 | $2.5B | Healthcare |
| 49 | MBX BIOSCIENCES INC | MBX | 0.48% | $9.2M | 304,600 | -24.4 | $2.8B | Healthcare |
| 50 | MINERALYS THERAPEUTICS INC | MLYS | 0.46% | $8.8M | 331,100 | -5.6 | $2.1B | Healthcare |